Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin

por Maihöfner, Christian, Diel, Ingo, Tesch, Hans, Quandel, Tamara, Baron, Ralf
Publicado 2021

Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality o...

por Schuette, Wolfgang, Tesch, Hans, Büttner, Hartwig, Krause, Thomas, Soldatenkova, Victoria, Stoffregen, Clemens
Publicado 2012

Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project

por Hurtz, Hans-Jürgen, Tesch, Hans, Göhler, Thomas, Hutzschenreuter, Ulrich, Harde, Johanna, Kruggel, Lisa, Jänicke, Martina, Marschner, Norbert
Publicado 2017

Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study

por Dörfel, Steffen, Steffens, Claus-Christoph, Meyer, Dirk, Tesch, Hans, Kruggel, Lisa, Frank, Melanie, Jänicke, Martina, Marschner, Norbert
Publicado 2017

Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study

por Kolberg, Hans-Christian, Colleoni, Marco, Demetriou, Georgia Savva, Santi, Patricia, Tesch, Hans, Fujiwara, Yasuhiro, Tomasevic, Zorica, Hanes, Vladimir
Publicado 2020

Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients wi...

por Hardtstock, Fränce, Kocaata, Zeki, Wilke, Thomas, Dittmar, Axel, Ghiani, Marco, Belozeroff, Vasily, Harrison, David J., Maywald, Ulf, Tesch, Hans
Publicado 2021

Clinical experience with Zarzio® in Europe: what have we learned?

por Gascón, Pere, Tesch, Hans, Verpoort, Karl, Rosati, Maria Sofia, Salesi, Nello, Agrawal, Samir, Wilking, Nils, Barker, Helen, Muenzberg, Michael, Turner, Matthew
Publicado 2013

Trastuzumab in advanced breast cancer – a decade of experience in Germany

por Jackisch, Christian, Schoenegg, Winfried, Reichert, Dietmar, Welslau, Manfred, Selbach, Johannes, Harich, Hanns-Detlev, Tesch, Hans, Wohlfarth, Tim, Eustermann, Heidi, Hinke, Axel
Publicado 2014

Cytoreductive treatment in real life: a chart review analysis on 1440 patients with polycythemia vera

por Crodel, Carl C., Jentsch-Ullrich, Kathleen, Reiser, Marcel, Jacobasch, Lutz, Sauer, Annette, Tesch, Hans, Ulshöfer, Thomas, Wunschel, Regine, Palandri, Francesca, Heidel, Florian H.
Publicado 2021

Systemic therapy in metastatic renal cell carcinoma

por Bedke, Jens, Gauler, Thomas, Grünwald, Viktor, Hegele, Axel, Herrmann, Edwin, Hinz, Stefan, Janssen, Jan, Schmitz, Stephan, Schostak, Martin, Tesch, Hans, Zastrow, Stefan, Miller, Kurt
Publicado 2016

P957: AN INDIRECT COMPARISON OF ELRANATAMAB’S (ELRA) OBJECTIVE RESPONSE RATE (ORR) FROM MAGNETISMM-3 (MM-3) VERSUS REAL-WORLD EXTERNAL CONTROL ARMS IN TRIPLE-CLASS REFRACTORY (TCR)...

por Costa, Luciano, Leblanc, Thomas W, Tesch, Hans, Sonneveld, Pieter, Kyle, Ryan, Sinyavskaya, Liliya, Hlavacek, Patrick, Meche, Aster, Ren, Jinma, Schepart, Alex, Aydin, Didem, Dibonaventura, Marco
Publicado 2023

P679: SPOTLIGHT ON THE REAL-WORLD TREATMENT OF CML PTS IN GERMANY: A RETROSPECTIVE SURVEY IN PRIVATE ONCOLOGY PRACTICES

por Franke, Georg-Nikolaus, Loewe, Gunnar, Reiser, Marcel, Linde, Hartmut, Josting, Andreas, von der Heyde, Eyck, Weide, Rudolf, Tesch, Hans, Nusch, Arndt, Dengler, Jolanta, Jentsch-Ullrich, Kathleen
Publicado 2023

Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations

por Aapro, Matti, Boccia, Ralph, Leonard, Robert, Camps, Carlos, Campone, Mario, Choquet, Sylvain, Danova, Marco, Glaspy, John, Hus, Iwona, Link, Hartmut, Sliwa, Thamer, Tesch, Hans, Valero, Vicente
Publicado 2017

Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phas...

por Koschmieder, Steffen, Isfort, Susanne, Schulte, Clemens, Jacobasch, Lutz, Geer, Thomas, Reiser, Marcel, Koenigsmann, Michael, Heinrich, Bernhard, Wehmeyer, Jürgen, von der Heyde, Eyck, Tesch, Hans, Gröschl, Benedikt, Bachhuber, Petra, Großer, Susanne, Pahl, Heike L.
Publicado 2023

Diagnosis and treatment of MPN in real life: exploratory and retrospective chart review including 960 MPN patients diagnosed with ET or MF in Germany

por Schmidt, Andreas, Bernhardt, Christiane, Bürkle, Dieter, Fries, Stefan, Hannig, Carla V., Jentsch-Ullrich, Kathleen, Josting, Andreas, Kreher, Stephan, Reiser, Marcel, Steinmetz, Hans Tilman, Tesch, Hans, Terner, Stephanie, Schulte, Alexander, Crodel, Carl C., Palandri, Francesca, Heidel, Florian H.
Publicado 2023

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

por Rack, Brigitte, Schindlbeck, Christian, Jückstock, Julia, Andergassen, Ulrich, Hepp, Philip, Zwingers, Thomas, Friedl, Thomas W. P., Lorenz, Ralf, Tesch, Hans, Fasching, Peter A., Fehm, Tanja, Schneeweiss, Andreas, Lichtenegger, Werner, Beckmann, Matthias W., Friese, Klaus, Pantel, Klaus, Janni, Wolfgang
Publicado 2014

The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemes...

por Hadji, Peyman, Stoetzer, Oliver, Decker, Thomas, Kurbacher, Christian M., Marmé, Frederik, Schneeweiss, Andreas, Mundhenke, Christoph, Distelrath, Andrea, Fasching, Peter A., Lux, Michael P., Lüftner, Diana, Janni, Wolfgang, Muth, Mathias, Kreuzeder, Julia, Quiering, Claudia, Grischke, Eva-Marie, Tesch, Hans
Publicado 2018

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor‐positive, human epidermal growth factor receptor 2‐negative locally advanced or meta...

por Tesch, Hans, Stoetzer, Oliver, Decker, Thomas, Kurbacher, Christian M., Marmé, Frederik, Schneeweiss, Andreas, Mundhenke, Christoph, Distelrath, Andrea, Fasching, Peter A., Lux, Michael P., Lüftner, Diana, Hadji, Peyman, Janni, Wolfgang, Muth, Mathias, Kreuzeder, Julia, Quiering, Claudia, Taran, Florin‐Andrei
Publicado 2018

HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer

por Denkert, Carsten, Huober, Jens, Loibl, Sibylle, Prinzler, Judith, Kronenwett, Ralf, Darb-Esfahani, Silvia, Brase, Jan C, Solbach, Christine, Mehta, Keyur, Fasching, Peter A, Sinn, Bruno V, Engels, Knut, Reinisch, Mattea, Hansmann, Martin-Leo, Tesch, Hans, von Minckwitz, Gunter, Untch, Michael
Publicado 2013

Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer – Results of the Germa...

por Jueckstock, Julia, Rack, Brigitte, Friedl, Thomas W. P., Scholz, Christoph, Steidl, Julia, Trapp, Elisabeth, Tesch, Hans, Forstbauer, Helmut, Lorenz, Ralf, Rezai, Mahdi, Häberle, Lothar, Alunni-Fabbroni, Marianna, Schneeweiss, Andreas, Beckmann, Matthias W., Lichtenegger, Werner, Fasching, Peter A., Pantel, Klaus, Janni, Wolfgang
Publicado 2016